QIAGEN Digital Insights Customer Research
When you have identified a pathway from a metagenomic functional profiling analysis, which steps do you typically perform subsequently?
Identification of central nodes/enzymes as drug targets |
|
|
Identification of the phenotypic consequences of differential abundance/expression |
|
|
Identification of harmful/beneficial metabolites |
|
|
Other |
|